BackSol-Gel Technologies Overview

Sol-Gel Technologies Total Current Liabilities

Latest total current liabilities for SLGL: $4.9M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$4.93M
0.57% YoYΔ $-28000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Sol-Gel Technologies Total Current Liabilities History

Loading

Sol-Gel Technologies vs. peers: Total Current Liabilities Comparison

Loading

Sol-Gel Technologies Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sol-Gel Technologies (SLGL) FAQ

The latest total current liabilities for SLGL is $4.9M as of June 2026. That compares with $5M in the prior-year period — down 0.6% year over year. Investors often review this figure alongside Sol-Gel Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, SLGL's total current liabilities moved from $5M to $4.9M — a 0.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sol-Gel Technologies's operating scale or balance-sheet position.

A total current liabilities figure of $4.9M for SLGL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SLGL's total current liabilities ($4.9M), review year-over-year change from $5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sol-Gel Technologies's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.